Home4503 • TYO
Astellas Pharma Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 459.29B | 10.78% |
Operating expense | 328.33B | 16.59% |
Net income | 74.90B | 325.06% |
Net profit margin | 16.31 | 303.11% |
Earnings per share | — | — |
EBITDA | 101.79B | -6.11% |
Effective tax rate | -23.68% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 188.37B | -43.88% |
Total assets | 3.34T | -6.44% |
Total liabilities | 1.83T | -7.46% |
Total equity | 1.51T | — |
Shares outstanding | 1.79B | — |
Price to book | 1.65 | — |
Return on assets | 3.98% | — |
Return on capital | 5.69% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 74.90B | 325.06% |
Cash from operations | 101.08B | 40.42% |
Cash from investing | -2.97B | 86.62% |
Cash from financing | -90.81B | -393.61% |
Net change in cash | 8.51B | -89.59% |
Free cash flow | 50.68B | -8.05% |
Previous close
¥1,390.50
Day range
¥1,392.50 - ¥1,419.50
Year range
¥1,243.50 - ¥1,835.00
Market cap
2.52T JPY
Avg Volume
6.72M
P/E ratio
49.33
Dividend yield
5.31%
Primary exchange
TYO
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,754
